VivoSim Labs (VIVS) Total Liabilities (2010 - 2026)
VivoSim Labs (VIVS) posted Total Liabilities of $6.2 million for Q2 2026, down 27.01% on a QoQ basis from $8.5 million in Q1 2026, and up 153.81% year-over-year from $2.4 million in Q2 2025.
Analysis
VivoSim Labs (VIVS) Total Liabilities (2010 - 2026) Analysis & Trends
VivoSim Labs has reported Total Liabilities for 17 years, with the latest figure at $6.2 million in Q2 2026.
- On a quarterly basis, Total Liabilities rose 153.81% year-over-year to $6.2 million in Q2 2026; TTM through Jun 2026 was $6.2 million, a 153.81% increase from a year earlier, with the FY2026 full-year figure at $8.5 million, up 104.06% from the prior year.
- Total Liabilities was $6.2 million for Q2 2026 at VivoSim Labs, down from $8.5 million in the prior quarter.
- The five-year high for Total Liabilities was $8.5 million in Q1 2026, with the low at $2.4 million in Q2 2025.
- Average Total Liabilities over 5 years is $3.5 million, with a median of $2.9 million recorded in 2022.
- The sharpest annual moves came in 2022 and 2024: Total Liabilities jumped 328.16% in 2022, then slumped 44.86% in 2024.
- Over 5 years, Total Liabilities stood at $2.8 million in 2022, then slipped by 3.26% to $2.7 million in 2023, then advanced by 28.94% to $3.5 million in 2024, then slipped by 27.61% to $2.5 million in 2025, then soared by 145.85% to $6.2 million in 2026.
- The last three Total Liabilities figures came in at $6.2 million (Q2 2026), $8.5 million (Q1 2026), and $2.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 23.58 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 1.62 Bn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 7.02 Bn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 4.64 Bn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 2.19 Bn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 1.06 Bn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 569.76 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 28.83 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 7.47 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 6.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.19 Mn |
| Mar 31, 2026 | 8.49 Mn |
| Dec 31, 2025 | 2.52 Mn |
| Sep 30, 2025 | 2.62 Mn |
| Jun 30, 2025 | 2.44 Mn |
| Mar 31, 2025 | 4.16 Mn |
| Dec 31, 2024 | 3.48 Mn |
| Sep 30, 2024 | 3.07 Mn |
| Jun 30, 2024 | 2.81 Mn |
| Mar 31, 2024 | 2.75 Mn |
| Dec 31, 2023 | 2.70 Mn |
| Sep 30, 2023 | 2.71 Mn |
| Jun 30, 2023 | 2.98 Mn |
| Mar 31, 2023 | 4.98 Mn |
| Dec 31, 2022 | 2.79 Mn |
| Sep 30, 2022 | 2.90 Mn |
| Jun 30, 2022 | 2.89 Mn |
| Mar 31, 2022 | 3.09 Mn |
| Dec 31, 2021 | 3.80 Mn |
| Sep 30, 2021 | 1.68 Mn |